Evaluation of GORE® ENFORM Biomaterial for Hernia Repair
Official title: GORE® ENFORM Biomaterial Product Study: A Study to Describe Multi-use Biomaterial Performance in Hernia Patients
Run by W.L.Gore & Associates · NCT04718168 · Data updated 2026-11-12
This study is testing a new material for hernia repair to see how well it works and how patients feel about it after surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 245 (estimated) |
| Sponsor | W.L.Gore & Associates Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 9 sites (San Diego, California and 8 other locations) |
| Status | Recruiting |
| Started | May 17, 2021 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT04718168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who require surgical repair of a single site ventral or hiatal hernia.
✕Probably not a fit
Patients with complex hernia repairs or those who have been involved in other clinical studies within the past year may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the GORE® ENFORM Biomaterial in patients undergoing repair for various types of hernias, including ventral, hiatal, and diaphragmatic hernias. It is a multicenter, non-randomized study that collects data on the functional performance of the biomaterial and the short-term patient experience. Participants will be monitored for their surgical outcomes and overall satisfaction with the treatment. The study aims to provide insights into the effectiveness of this biomaterial in hernia repair procedures.
Why it matters
Potential benefit: If successful, this study could improve surgical outcomes and patient satisfaction in hernia repair procedures.
How similar studies have gone: Other studies have shown promising results with similar biomaterials in hernia repair, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Pre-procedure Inclusion Criteria: The subject is / has: 1. At least 18 years old at the time of informed consent. Minimum age required by state regulations (as applicable). 2. An expected scored Class I (Clean) surgical wound using CDC Surgical Wound Classification system. 3. A planned implant with GORE® ENFORM Biomaterial for a single site ventral or hiatal hernia repair as suture line reinforcement. 4. An expected scored Grade 1 or Grade 2 using the Ventral Hernia Working Group Grading system. 5. Willing to provide informed consent and comply with follow-up requirements. Pre-procedure Exclusion Criteria: The subject is / has: 1. Treated in another drug or medical device study within 1 year of study enrollment. 2. Implanted with GORE® ENFORM Biomaterial in the reconstruction of cardiovascular defects. 3. Hernia repair expected to be performed as part of a bridged procedure (i.e., expected inability to perform primary closure of fascia or crura, patients requiring permanent support from the device). 4. A BMI \>40. 5. Evidence of a systemic infection. 6. Cirrhosis or undergoing dialysis. 7. A wound-healing disorder. 8. Immunocompromised such as, with HIV or transplant, or receiving chemo or radiation therapy. 9. Expected to undergo mesh implantation in conjunction with any bariatric procedure and / or panniculectomy procedure. 10. A stoma. 11. Co-morbid conditions that may limit their ability to comply with study and follow-up requirements. 12. Positive pregnancy or lactation status as confirmed by site standard of care. 13. Hernias requiring treatment within multiple body regions or expected use of multiple hernia mesh devices. Post-procedure Inclusion Criteria At the time of index procedure, the subject is / has: 1. At least 18 years old. Minimum age required by state regulations (as applicable). 2. Implanted with GORE® ENFORM Biomaterial for a single site ventral or hiatal hernia repair as suture-line reinforcement on or before 365 days prior to site protocol amendment 3 approval date. 3. Unless there is an Informed Consent waiver issued by the Institutional Review Board (IRB), an Informed Consent Form (ICF) signed by subject. Post-procedure Exclusion Criteria At the time of index procedure, the subject is / has: 1. Treated in another drug or medical device study within 1 year of study enrollment. 2. Implanted with GORE® ENFORM Biomaterial in the reconstruction of cardiovascular defects. 3. Hernia repair that was performed as part of a bridged procedure (i.e., inability to perform primary closure of fascia or crura, patients requiring permanent support from the device). 4. A BMI \>40. 5. Evidence of a systemic infection. 6. Cirrhosis or undergoing dialysis. 7. A wound-healing disorder. 8. Immunocompromised such as, with HIV or transplant, or receiving chemo or radiation therapy. 9. Underwent mesh implantation in conjunction with any bariatric procedure and / or panniculectomy procedure. 10. A stoma. 11. Co-morbid conditions that may limit their ability to comply with study and follow-up requirements. 12. Positive pregnancy or lactation status as confirmed by site standard of care. 13. Hernias requiring treatment within multiple body regions or expected use of multiple hernia mesh devices.
Where it's running
-
University of California - San Diego
San Diego, California, United States Recruiting -
Institute of Esophageal and Reflux Surgery
Denver, Colorado, United States Recruiting -
Northshore University Health System Research Institute
Evanston, Illinois, United States Recruiting -
University of Kentucky
Lexington, Kentucky, United States Recruiting -
Prisma Health - Upstate
Greenville, South Carolina, United States Recruiting -
University of Texas Health Science Center at Houson
Houston, Texas, United States Recruiting
Show 3 more locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting -
Sarasota Memorial HealthCare System
Sarasota, Florida, United States Completed -
Atrium Health
Charlotte, North Carolina, United States Completed
Study contacts
- Principal investigator: Todd Heniford, MD — Endeavor Health
- Study coordinator: Mary Wexler
- Email: mwexler@wlgore.com
- Phone: 928-266-6512
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Risk factors for mesh infection after abdominal wall reconstruction
This study tests which factors put adults at risk for mesh infection after abdominal wall reconstruction using different mesh types.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
-
No abdominal incision in minimally invasive colorectal surgery: a multicenter registry of natural orifice specimen extraction
This registry follows adults having minimally invasive colorectal surgery to compare outcomes when the specimen is removed through a natural opening versus through an abdominal incision.
-
Compliance-guided Closure Strategy for Large Ventral Hernia Repair
This study tests whether using a structured intraoperative plan based on respiratory system stiffness helps decide how to close the abdominal wall in people with large ventral hernias.
-
Pre‑surgery optimisation for ventral hernia repair
This trial tests whether a structured pre-surgery programme to boost activity, encourage weight loss, and optimise other health problems helps adults with 4–8 cm ventral hernias have fewer complications after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.